H2AX and lung cancer: Similarly, knock down of ERK3 (shERK3/siCtrl, Figure 3A), TDP2 (shGIPZ/siTDP2, Figure 3A) or both (shERK3/siTDP2, Figure 3A) increased γ-H2AX in A549 lung cancer cells treated with etoposide.